SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma

Background and Objective. Serine hydroxymethyltransferase 2 (SHMT2) functions as a key enzyme in serine/glycine biosynthesis and one-carbon metabolism. Recent studies have shown that SHMT2 participated in tumor growth and progression in a variety of cancer types. The objective of the present study i...

Full description

Bibliographic Details
Main Authors:	Shanglei Ning, Siquan Ma, Abdul Qahar Saleh, Lingyu Guo, Zixiao Zhao, Yuxin Chen
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2018/4369253

Similar Items

Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer
by: Peng Zhang, et al.
Published: (2021-06-01)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
by: Meng Sha, et al.
Published: (2019-03-01)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
by: Zhi-Qiang Hu, et al.
Published: (2020-12-01)

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
by: Xiaobo Cai, et al.
Published: (2018-03-01)

Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.
by: Chi Zhang, et al.
Published: (2013-01-01)

Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients
by: Qiao Wu, et al.
Published: (2020-01-01)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
by: Peipei Song, et al.
Published: (2019-10-01)

CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis
by: Yamaoka, Ryoya
Published: (2019)

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance
by: Peng R, et al.
Published: (2017-12-01)

High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
by: Jing Jin, et al.
Published: (2014-01-01)

Intrahepatic cholangiocarcinoma
by: A. B. Luk’yanchenko, et al.
Published: (2016-02-01)

Preoperative risk grade predicts the long-term prognosis of intrahepatic cholangiocarcinoma: a retrospective cohort analysis
by: Jianping Zhao, et al.
Published: (2021-03-01)

CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma
by: Gong -Kai Huang, et al.
Published: (2017-06-01)

Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
by: Tai-Jan Chiu, et al.
Published: (2020-01-01)

High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma
by: Yu Huang, et al.
Published: (2018-01-01)

An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
by: He C, et al.
Published: (2021-05-01)

Effect of Y-box binding protein 1 overexpression on the prognosis of patients with intrahepatic cholangiocarcinoma undergoing postoperative adjuvant chemotherapy
by: LIU Heng, et al.
Published: (2017-02-01)

Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
by: Zhi-Zhong Wu, et al.
Published: (2020-10-01)

Intrahepatic mucinous cholangiocarcinoma
by: Bor‐Yow Lin, et al.
Published: (2020-09-01)

Asbestos and Intrahepatic Cholangiocarcinoma
by: Giovanni Brandi, et al.
Published: (2020-02-01)

Intrahepatic Sarcomatoid Cholangiocarcinoma
by: Shalini Malhotra, et al.
Published: (2010-01-01)

Management of Intrahepatic Cholangiocarcinoma
by: Sudha Kodali, et al.
Published: (2021-05-01)

The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma
by: Soliani Paolo, et al.
Published: (2007-12-01)

High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin
by: Gunn Huh, et al.
Published: (2020-09-01)

CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
by: Dalong Sun, et al.
Published: (2020-01-01)

Intrahepatic Cholangiocarcinoma Associated with Intrahepatic Duct Stones
by: Hoon Hur, et al.
Published: (2009-01-01)

MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma
by: Xijuan Ma, et al.
Published: (2020-06-01)

Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma
by: Seorin Jeong, et al.
Published: (2017-08-01)

Sarcomatoid change in intrahepatic cholangiocarcinoma
by: Albrechtsen Wewer Nicolai, et al.
Published: (2013-03-01)

Intrahepatic cholangiocarcinoma: current perspectives
by: Buettner S, et al.
Published: (2017-02-01)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
by: Yoshiyuki Inoue, et al.
Published: (2012-01-01)

Diagnosis strategies for intrahepatic cholangiocarcinoma
by: SU Lihong, et al.
Published: (2017-01-01)

Serum Markers of Intrahepatic Cholangiocarcinoma
by: Giulia Malaguarnera, et al.
Published: (2013-01-01)

SARCOMATOID CHANGE IN INTRAHEPATIC CHOLANGIOCARCINOMA
by: Wewer Albrechtsen, et al.
Published: (2013-01-01)

SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis.
by: Donald D Anderson, et al.
Published: (2009-06-01)

Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma
by: Sukanya Luang, et al.
Published: (2020-11-01)

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
by: Rui Zhang, et al.
Published: (2021-02-01)

Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
by: Chao Huang, et al.
Published: (2020-07-01)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
by: Jin Jingchun, et al.
Published: (2012-10-01)

Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
by: Wenjie Liang, et al.
Published: (2018-09-01)